GlassScriptPhysician profile
Jill Wirth Rissman
NPI 1003028150
$1,354.63
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $186 · 2021: $144 · 2022: $37.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $187.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $156.15 | 2019-2020 | |
| Pfizer INC. | $143.66 | 2019-2021 | |
| Allergan, INC. | $132.67 | 2019 | |
| Amgen INC. | $91.46 | 2019-2020 | |
| Glaxosmithkline, LLC. | $83.61 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $78.90 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.59 | 2019-2021 | |
| Abbott Laboratories | $72.85 | 2020-2022 | |
| Amarin Pharma, INC. | $46.91 | 2019 | |
| Astellas Pharma US INC | $31.88 | 2019 | |
| Lilly USA, LLC | $28.95 | 2019-2020 | |
| Fidia Pharma USA INC. | $25.28 | 2019 | |
| Bioventus LLC | $24.95 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $22.15 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $20.70 | 2019 | |
| Merck Sharp & Dohme LLC | $17.89 | 2019 | |
| Orthofix Medical, INC. | $16.33 | 2022 | |
| Mission Pharmacal Company | $16.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.31 | 2019 | |
| Radius Health, INC. | $14.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.73 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.45 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.88 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Wirth Rissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.